NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
key details
| Value | £33,981,928 (£40,778,314 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West, Yorkshire and the Humber, London |
| Deadline | 9 Mar 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-051c39 |
Awards (11)
This procurement was awarded to 11 suppliers. Values shown are per-award; the notice total is £33,981,928.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK Ltd shared | £19,595,208 | 24 Mar 2026 | active |
| Amarox Limited shared | £19,595,208 | 24 Mar 2026 | active |
| Lipomed AG shared | £19,595,208 | 24 Mar 2026 | active |
| Milpharm Ltd shared | £19,595,208 | 24 Mar 2026 | active |
| Reig Jofre UK limited shared | £19,595,208 | 24 Mar 2026 | active |
| SUN PHARMA UK LIMITED shared | £19,595,208 | 24 Mar 2026 | active |
| Teva UK Limited shared | £19,595,208 | 24 Mar 2026 | active |
| Thornton and Ross Ltd shared | £19,595,208 | 24 Mar 2026 | active |
| Viatris UK Healthcare Limited shared | £19,595,208 | 24 Mar 2026 | active |
| Wockhardt UK Limited shared | £19,595,208 | 24 Mar 2026 | active |
| Zentiva Pharma UK Ltd shared | £19,595,208 | 24 Mar 2026 | active |
description
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
Offer reference number: CM/PHG/24/5716
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
documents
- https://www.find-tender.service.gov.uk/Notice/010573-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11587 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
5 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 024360-2025 |
| 23 Jan 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 006070-2026 |
| 5 Feb 2026 | Tender notice (UK4) | Procurement Act 2023 | 010573-2026 |
| 26 Mar 2026 | Contract award (UK6) | Procurement Act 2023 | 027870-2026 |
| 28 May 2026 | Contract details (UK7) | Procurement Act 2023 | 050525-2026 |
more from NHS England
- Membership of London Higher Academic Organisation · £16,550 · 11 Sept 2026
- Babies, Children and Young People Modern Service Framework · · · 10 Sept 2026
- Primary Care Virtual Licences · £19,940 · 10 Sept 2026
- Access to medicine and the professions 2026/27 · £115,000 · 10 Sept 2026
- SANS Training 26/27 · £400,000 · 9 Sept 2026
- Discovery into the Professionalisation of the NHS DDaT Workforce · £50,000 · 8 Sept 2026
- NHS Graduate Management Training Scheme(GMTS) Engineering and Estates Management - NHSE · £825,000 · 8 Sept 2026
- Elizabeth Garrett Anderson Programme – Primary Care Manchester University · £662,000 · 7 Sept 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.